---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-018505"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2023-02-10T23:59:59+00:00"
generated_at: "2026-06-19T17:49:44.473430+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ReShape Lifesciences closes upsized $10.2M public offering of units with warrants

## Summary
- Offered 1,275,000 units at $8.00/unit; each unit: 1 share (or pre-funded warrant) + 1 warrant for 1.5 shares.
- Gross proceeds $10.2M; net proceeds ~$9.1M after underwriting discounts and expenses.
- Warrants: exercise price $8.00/share, 5-year term; alternative cashless exercise yields 0.75 shares per warrant.
- Overallotment exercised for additional warrants to purchase 286,875 shares of common stock.
- Proceeds to fund growth strategies, working capital, and general corporate purposes.

## SEC filing metadata
- accession: 0001104659-23-018505
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2023-02-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000110465923018505/0001104659-23-018505-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000110465923018505/tm236268d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-018505
- JSON: https://secwatch.observer/filing/0001104659-23-018505.json
- Plain text: https://secwatch.observer/filing/0001104659-23-018505.txt

## Key facts
- Material Agreements
  Vyome Holdings, Inc entered into Underwriting Agreement with Maxim Group LLC valued at $8.00 per Unit (effective 2023-02-06).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Maxim Group LLC
  - Value: $8.00 per Unit
  - Effective: 2023-02-06
  source text: On February 6, 2023, ReShape Lifesciences Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Maxim Group LLC
  evidence_url: https://www.sec.gov/Archives/edgar/data/1427570/000110465923018505/0001104659-23-018505-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.